Detalhe da pesquisa
1.
Life histories of myeloproliferative neoplasms inferred from phylogenies.
Nature
; 602(7895): 162-168, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35058638
2.
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.
Blood
; 143(2): 178-182, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37963262
3.
Essential thrombocythemia: challenges in clinical practice and future prospects.
Blood
; 141(16): 1943-1953, 2023 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36379024
4.
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
N Engl J Med
; 379(15): 1416-1430, 2018 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30304655
5.
Changes in practice within a haematological malignancy diagnostic service: A 5-year retrospective study.
Br J Haematol
; 2024 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38736140
6.
The management of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 136-150, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38037886
7.
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 127-135, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37932932
8.
Clonal hematopoiesis is not significantly associated with COVID-19 disease severity.
Blood
; 140(14): 1650-1655, 2022 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35839449
9.
Effect of mutation order on myeloproliferative neoplasms.
N Engl J Med
; 372(7): 601-612, 2015 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-25671252
10.
Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.
Blood
; 137(21): 2992-2997, 2021 05 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33598691
11.
JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response.
Proc Natl Acad Sci U S A
; 111(42): 15190-5, 2014 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25288776
12.
The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders.
Br J Haematol
; 195(3): 338-351, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34409596
13.
JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease.
Blood
; 123(20): 3139-51, 2014 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24692758
14.
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.
Blood
; 120(13): 2704-7, 2012 Sep 27.
Artigo
Inglês
| MEDLINE | ID: mdl-22898600
15.
Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms.
Nat Genet
; 56(2): 273-280, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38233595
16.
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.
Br J Haematol
; 160(1): 25-34, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23057517
17.
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Blood
; 118(24): 6239-46, 2011 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-21998214
18.
Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemia.
Haematologica
; 98(5): 718-21, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23633544
19.
Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy.
Nat Cancer
; 4(8): 1095-1101, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37474833
20.
Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.
Leukemia
; 37(2): 348-358, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36470992